BioCentury
ARTICLE | Clinical News

Doxil liposomal doxorubicin data

August 19, 1996 7:00 AM UTC

SEQU released data showing superior efficacy of Doxil compared to bleomycin and vincristine chemotherapy. Patients with advanced disease showed a 58.7 percent total response with Doxil, compared to 23.3 percent after the combination chemotherapy. A total of 241 patients were enrolled in the trial. ...